WallStSmart
ABUS

Arbutus Biopharma Corp

NASDAQ: ABUS · HEALTHCARE · BIOTECHNOLOGY

$4.13
-0.48% today

Updated 2026-04-29

Market cap
$813.36M
P/E ratio
P/S ratio
57.75x
EPS (TTM)
$-0.17
Dividend yield
52W range
$3 – $5
Volume
2.5M

Arbutus Biopharma Corp (ABUS) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$13.60M$15.92M$9.64M$13.78M$21.35M$16.30M$14.18M$15.46M$15.00M$24.87M$1.50M$10.70M$5.90M$6.01M$6.91M$10.99M$39.02M$18.14M$6.17M$14.08M
Revenue growth (YoY)+17.0%-39.5%+42.9%+55.0%-23.6%-13.0%+9.0%-3.0%+65.8%-94.0%+613.3%-44.9%+1.9%+15.0%+58.9%+255.1%-53.5%-66.0%+128.2%
Cost of revenue$6.19M$12.79M$13.25M$16.97M$22.13M$19.49M$18.13M$21.46M$38.70M$51.51M$61.30M$62.70M$57.90M$57.60M$47.48M$1.75M$1.43M$73.70M$1.38M$363000.00
Gross profit$7.42M$15.92M$-3.61M$-3.19M$-779120.00$-3.19M$-3.94M$-5.99M$-23.70M$-26.63M$-59.80M$-52.00M$-52.00M$-51.59M$-40.57M$10.99M$39.02M$18.14M$6.17M$13.72M
Gross margin54.5%100.0%-37.4%-23.1%-3.6%-19.5%-27.8%-38.8%-158.0%-107.1%-3986.7%-486.0%-881.4%-858.3%-586.7%100.0%100.0%100.0%100.0%97.4%
R&D$4.53M$8.43M$13.25M$16.89M$22.13T$19.51M$18.13M$21.46M$38.70M$51.51M$61.30M$62.70M$57.90M$57.60M$49.34M$65.50M$84.41M$73.70M$54.04M$25.24M
SG&A$3.85M$4.44M$3.62M$3.97M$4.78M$6.18M$26.89M$5.55M$8.70M$26.44M$39.40M$16.10M$16.00M$17.73M$14.85M$17.14M$17.83M$22.48M$22.11M$15.89M
Operating income$-1.68M$2.64M$-10.95M$-9.07M$-12.51M$-10.32M$-12.99M$-12.15M$-33.00M$-102.32M$-491.60M$-110.90M$-89.80M$-143.90M$-57.81M$-73.52M$-65.46M$-78.10M$-76.32M$-27.05M
Operating margin-12.4%16.6%-113.6%-65.8%-58.6%-63.3%-91.6%-78.6%-220.0%-411.4%-32773.3%-1036.4%-1522.0%-2394.0%-836.1%-669.1%-167.8%-430.5%-1236.7%-192.1%
EBITDA$20.97M$3.05M$-7.23M$-6.74M$-11.05M$-9.06M$34.18M$-11.54M$-32.44M$-76.72M$-488.07M$-106.44M$-58.95M$-162.24M$-57.76M$-71.64M$-61.86M$-70.99M$-68.40M$-26.69M
EBITDA margin154.1%19.2%-75.0%-48.9%-51.7%-55.6%241.1%-74.6%-216.3%-308.4%-32538.3%-994.8%-999.2%-2699.1%-835.3%-652.0%-158.5%-391.3%-1108.5%-189.5%
EBIT$20.37M$2.64M$-8.34M$-8.65M$-12.08M$-10.01M$33.31M$-12.15M$-32.94M$-77.31M$-489.17M$-108.47M$-61.13M$-164.27M$-59.73M$-73.39M$-63.29M$-72.39M$-69.78M$-27.05M
Interest expense$1.61M$1.02M$0.00$156332.00$106939.00$76907.00$47000.00$539996.00$853000.00$674000.00$1.39M$261000.00$200000.00$2.11M$4.01M$2.86M$1.73M$459000.00$137000.00$97000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$18.08M$-2.58M$-11.72M$-9.33M$-12.41M$-9.73M$29.95M$-14.06M$-38.80M$-61.12M$-384.10M$-84.40M$-57.10M$-153.72M$-63.74M$-76.25M$-69.46M$-72.85M$-69.92M$-33.50M
Net income growth (YoY)-114.3%-353.7%+20.4%-33.1%+21.6%+407.7%-147.0%-175.9%-57.5%-528.4%+78.0%+32.3%-169.2%+58.5%-19.6%+8.9%-4.9%+4.0%+52.1%
Profit margin132.9%-16.2%-121.6%-67.7%-58.1%-59.7%211.2%-90.9%-258.7%-245.7%-25606.7%-788.8%-967.8%-2557.4%-922.0%-693.9%-178.0%-401.6%-1133.0%-237.9%